Gene · 1874
Papers2,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of self-renewal and senescence in primitive mesenchymal stem cells by Wnt and TGFβ signaling. | Stem Cell Res Ther | 2023 | 37880755 | PubTator, text mining | PubMed |
| Chromatin-modifying enzymes as modulators of nuclear size during lineage differentiation. | Cell Death Discov | 2023 | 37863956 | PubTator, text mining | PubMed |
| Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma. | Front Mol Biosci | 2023 | 37854038 | PubTator, text mining | PubMed |
| Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin. | Epigenetics | 2023 | 37838974 | PubTator, text mining | PubMed |
| Prenatal Metal Exposure Alters the Placental Proteome in a Sex-Dependent Manner in Extremely Low Gestational Age Newborns: Links to Gestational Age. | Int J Mol Sci | 2023 | 37834424 | PubTator, text mining | PubMed |
| p53 in the Molecular Circuitry of Bone Marrow Failure Syndromes. | Int J Mol Sci | 2023 | 37834388 | PubTator, text mining | PubMed |
| Transcriptional Regulation of Airway Epithelial Cell Differentiation: Insights into the Notch Pathway and Beyond. | Int J Mol Sci | 2023 | 37834236 | PubTator, text mining | PubMed |
| Glycolysis Promotes Angiotensin II-Induced Aortic Remodeling Through Regulating Endothelial-to-Mesenchymal Transition via the Corepressor C-Terminal Binding Protein 1. | Hypertension | 2023 | 37795602 | PubTator, text mining | PubMed |
| A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37791068 | PubTator, text mining | PubMed |
| A Positive Feedback Loop of E2F4-Mediated Activation of MNX1 Regulates Tumour Progression in Colorectal Cancer. | J Cancer | 2023 | 37779874 | PubTator, text mining | PubMed |
| CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor. | Sci Rep | 2023 | 37759078 | PubTator, text mining | PubMed |
| Molecular pathology of colorectal cancer: The Saudi situation in perspective. | Saudi Med J | 2023 | 37717975 | PubTator, text mining | PubMed |
| MBNL1‑AS1 attenuates tumor cell proliferation by regulating the miR‑29c‑3p/BVES signal in colorectal cancer. | Oncol Rep | 2023 | 37711058 | PubTator, text mining | PubMed |
| Inferring gene regulatory network from single-cell transcriptomes with graph autoencoder model. | PLoS Genet | 2023 | 37703293 | PubTator, text mining | PubMed |
| ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2. | Cancer Sci | 2023 | 37700392 | PubTator, text mining | PubMed |
| Human lncRNA SUGCT-AS1 Regulates the Proinflammatory Response of Macrophage. | Int J Mol Sci | 2023 | 37686120 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. | Commun Biol | 2023 | 37684337 | PubTator, text mining | PubMed |
| A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities. | Dis Model Mech | 2023 | 37661832 | PubTator, text mining | PubMed |
| Uncovering Novel Roles of miR-122 in the Pathophysiology of the Liver: Potential Interaction with NRF1 and E2F4 Signaling. | Cancers (Basel) | 2023 | 37627157 | PubTator, text mining | PubMed |
| Trim33 masks a non-transcriptional function of E2f4 in replication fork progression. | Nat Commun | 2023 | 37612308 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1874/papers?page=7